Scientists from Institute of Advanced Study in Science and Technology (IASST) an autonomous institute of the D...Read more
As the novel coronavirus (COVID-19) pandemic continues to spread globally, virtual platforms will experience a...Read more
The COVID-19 pandemic has prioritized healthcare worldwide and has highlighted the need to strengthen healthca...Read more
Merck, a leading science and technology company, and Baylor College of Medicine, Houston, Texas, USA have anno...Read more
Bengaluru based Indian Institute of Science (IISc), India’s leading institution for advanced education a...Read more
For a 52-year-old patient, life came to a standstill when he was diagnosed with prostate cancer. He knew that ...Read more
BUILDING INDIGENOUS DIAGNOSTIC CAPABILITIES
India is facing a bigger burden of not having enough diagnostic kits in hand. Specifically, there is a shortage of reagents and consumables required to carry out the diagnostic tests for COVID-19. In order to overcome this burden, India is reaching out to South Korea, USA, Germany and China to arrange for more kits in order to increase the current testing capacity for COVID-19. Although this step might help India to some extent in its current containment plan, the real need can only be fulfilled by accelerating indigenous COVID-19 diagnostics manufacturing.